Search Within

Eli Louis Diamond

  1. "Wiley Periodicals, Inc"
Formats
  1. Meeting Abstract (19)
  2. Journal Article (2)
Groups
  1. Center for Hematologic Malignancies (16)
  2. Department of Medicine (16)
  3. Hematologic Malignancies, Division of (16)
  4. Executive Committee, Center for Hematologic Malignancies (14)
  5. GSK Faculty (14)
  6. Tow Center for Developmental Oncology (TCDO) (14)

More Groups

People
  1. Omar Abdel-Wahab (14)
  2. Benjamin Durham (12)
  3. Raajit Rampal (8)
  4. David Hyman (6)
  5. Mario Lacouture (5)
  6. Kseniya Petrova-Drus (4)

More People

Years
  1. 2023 (6)
  2. 2022 (1)
  3. 2020 (1)
  4. 2019 (3)
  5. 2018 (2)
  6. 2017 (1)

More Years

Publications
  1. Pediatric Blood and Cancer (21)
Publishers
  1. Wiley Periodicals, Inc (21)

Results (21)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including novel treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Rosenblum, M.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V. M.; Hatzoglou, V.; Young, R.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Ocular findings in patients with histiocytosis
    Meeting Abstract

    Francis, J. H.; Reiner, A. S.; Canestraro, J.; Raajit, R.; Abramson, D. H.; Diamond, E. L.
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Efficacy of alpelisib in PI3K-driven langerhans cell histiocytosis
    Meeting Abstract

    Mazor, R. D.; Durham, B. H.; Abdel-Wahab, O. I.; Diamond, E. L.; Yabe, M.; Itchaki, G.; Ben-Sasson, M.; Hershkovitz-Rokah, O.; Shpilberg, O.
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Clinical resistance associated with a rare MAP2K1 mutation in an adult patient with multi-system langerhanscell-histiocytosis (MS-LCH)
    Meeting Abstract

    Rösler, W.; Balabanov, S.; Bühler, M.; Clarenbach, C.; Diamond, E.; Honecker, F.; Manz, M.
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Treatment outcomes of the rare histiocytic disorders: First descriptive analysis of the IRHDR-registry
    Meeting Abstract

    Abla, O.; Picarsic, J.; Emile, J. F.; Galluzzo, L.; Braier, J.; Felizzia, G.; Astigarraga, I.; Degar, B.; Classen, C.; van den Bos, C.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • A multinational series of 26 patients with mixed histiocytic neoplasms highlighting a diverse mutational landscape and superior efficacy of targeted therapies
    Meeting Abstract

    Diamond, E. L.; Durham, B. H.; Reiner, A. S.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Ulaner, G. A.; Reddy, R.; Lacouture, M. E.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • ALK+ histiocytosis: A new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
    Meeting Abstract

    Kemps, P.; Picarsic, J.; Durham, B. H.; Hélias-Rodzewicz, Z.; Hiemcke-Jiwa, L.; van den Bos, C.; van de Wetering, M. D.; van Noesel, C. J. M.; Hogendoorn, P. C. W.; Woei-A-Jin, F. J. S.; more...
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Novel alterations in CSF1R, RET, and other diverse kinases in the histiocytoses with biochemical and structural insights into their mechanisms of activation
    Meeting Abstract

    Durham, B.; Lopez-Rodrigo, E.; Picarsic, J.; Abramson, D.; Rotemberg, V.; De Munck, S.; Pannecoucke, E.; Lu, S.; Pastore, A.; Mandelker, D.; more...
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Genomic analysis of C-group juvenile xanthogranuloma family lesions identifies novel kinase alterations and distinctive morphologic patterns
    Meeting Abstract

    Picarsic, J.; Alaggio, R.; Jaffe, R.; Diamond, E. L.; Durham, B. H.; Abdel-Wahab, O.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Histology of Rosai-Dorfman disease in a subset of patients with Erdheim-Chester disease: A distinct entity mainly driven by MAP2K1
    Meeting Abstract

    Razanamahery, J.; Diamond, E.; Cohen-Aubart, F.; Karl-Heinz, P.; Charlotte, F.; Helias-Rodzewicz, Z.; Dogan, A.; Abdel-Wahab, O.; Durham, B.; Ozkaya, N.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save